Mitsubishi Chem: will buy capsule maker from Carlyle for $660M


Japan’s Mitsubishi Chemical Holdings Corp said it will acquire drug capsule maker Qualicaps Co Ltd from U.S.-based Carlyle Group LP for 55.8 billion yen ($660 million) to beef up its pharmaceutical operations, Reuters reported.

(Reuters) – Japan’s Mitsubishi Chemical Holdings Corp said it will acquire drug capsule maker Qualicaps Co Ltd from U.S.-based Carlyle Group LP for 55.8 billion yen ($660 million) to beef up its pharmaceutical operations.

Get your FREE trial or subscribe now to Buyouts to find new deal opportunities, super-charge your fundraising efforts and track top managers.

Sign up to our Newsletter

Receive updates from our PE HUB Wire and Top Stories of the Week newsletters:

We will not send you spam, and we don't share your email address with 3rd parties.